11051254Poelman SM, Adeyanju MO, Robertson MA, Recant WM, Karrison T, Fleming GF, Olopade OI, Conzen SDClinical cancer research : an official journal of the American Association for Cancer ResearchAntineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Resistance, Neoplasm; Paclitaxel; Proto-Oncogene Proteins c-bcl-2Adult; Aged; Disease-Free Survival; Female; Humans; Immunohistochemistry; Middle Aged; Time FactorsHuman breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression. Clin Cancer Res. 2000 Oct; 6(10):4043-8.Clin Cancer Res2000-10-01T00:00:002000Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD001943Disorders38828810.371998Breast NeoplasmsD000328Living Beings1578255770.254432AdultMedicine-Hematology/OncologyAuthorship 180808Authorship 180817D007150Procedures48817520.715464ImmunohistochemistryD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD013997Concepts & Ideas118351980.519628Time FactorsD019008Physiology1805890.751116Drug Resistance, Neoplasm0.1963090.04907724authors10.2513has subject areaMedicine-Hematology and OncologyD017239Chemicals & Drugs1164600.850613PaclitaxelD019253Chemicals & Drugs1011890.895533Proto-Oncogene Proteins c-bcl-2Public Health SciencesD000972Chemicals & Drugs672760.849787Antineoplastic Agents, Phytogenichttps://cgh.uchicago.edu/page/leadershipGlobal Healthhttps://www.uchicagomedicine.org/find-a-physician/physician/olufunmilayo-i-olopadeUChicago Medicinehttps://cancerbio.uchicago.edu/program/faculty/olufunmilayo-olopadeCancer Biologyhttps://www.uchicagomedicine.org/conditions-services/cancer/cancer-risk-preventionCancer Risk and PreventionD018572Concepts & Ideas25812030.792696Disease-Free SurvivalUniversity of ChicagoGiniFleming0GRlDqwcF+v5hHlsaUXv9Gq0+s+oGini Fleming41.78927490000000-87.601250000000001804Fleming, GiniProfessorOlufunmilayoOlopade321vBIF1GuTQkntjbwjr93A=Olufunmilayo Olopade41.78927490000000-87.601250000000001960Olopade, OlufunmilayoProfessorTheodoreKarrisonTheodore Karrison41.78927490000000-87.601250000000002356Karrison, TheodoreResearch ProfessorSuzanneConzenSuzanne D. Conzen41.78927490000000-87.60125000000000599Conzen, SuzanneProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Research ProfessorResearch ProfessorAuthorship 538905Authorship 538896